Publication | Open Access
Vascular endocan (ESM‐1) is markedly overexpressed in clear cell renal cell carcinoma
152
Citations
23
References
2009
Year
Our results showed that endocan is overexpressed in patients with RCC. Endocan could therefore appear as a marker of interest in the follow-up and may be a potential parameter to monitor the tumour response to anti-angiogenic therapeutics.
| Year | Citations | |
|---|---|---|
Page 1
Page 1